Literature DB >> 27366388

Diphenylhydantoin Induced DRESS Syndrome: A Case Report.

Figen Leblebici1, Özlem Soyal1, Nevzat Mehmet Mutlu1, Hatice Yağmurdur1, Onur Karaca1.   

Abstract

Drug Rash with Eosinophilia and Systemic Symptoms" (DRESS) syndrome is a severe adverse drug reaction. The drugs most often implicated are anti-convulsants, bupropion, sulfonamides, sulfasalazine, allopurinol, minocycline, abacavir and neviparine. There are also immune and infectious causes that can lead to DRESS syndrome. A 70-year-old female patient had undergone endovascular coil embolization for intracranial aneurysm and experienced a generalised seizure postoperatively. She had been given diphenylhidantoin (DPH). Six days after DPH therapy, the patient had complained of widespread skin rash. Although DPH was replaced with levetiracetam afterwards, the skin rash deteriorated, causing facial oedema and swelling of the tongue. She had severe facial oedema with swelling of the tongue, causing disturbance of breathing. On the second day in the critical care unit, the patient's breathing deteriorated, leading successively to intubation and mechanical ventilation. The patient's rash was still persistent and the results of a punch biopsy taken from the lesions revealed superficial perivascular dermatitis involving spongiotic eosinophils compatible with spongiotic drug eruption. As a result, it is important to realise that medications we use can be the cause of a range of reactions ranging from simple rash to life threatening syndromes.

Entities:  

Keywords:  Drug reactions; diphenylhidantoin; dress syndrome

Year:  2013        PMID: 27366388      PMCID: PMC4894106          DOI: 10.5152/TJAR.2013.44

Source DB:  PubMed          Journal:  Turk J Anaesthesiol Reanim        ISSN: 2149-276X


  12 in total

1.  Hypersensitivity syndrome associated with efavirenz therapy.

Authors:  P Bossi; D Colin; F Bricaire; E Caumes
Journal:  Clin Infect Dis       Date:  2000-01       Impact factor: 9.079

2.  Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?

Authors:  S H Kardaun; A Sidoroff; L Valeyrie-Allanore; S Halevy; B B Davidovici; M Mockenhaupt; J C Roujeau
Journal:  Br J Dermatol       Date:  2007-03       Impact factor: 9.302

Review 3.  Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS).

Authors:  H Bocquet; M Bagot; J C Roujeau
Journal:  Semin Cutan Med Surg       Date:  1996-12

4.  Drug rash, eosinophilia, and systemic symptoms syndrome: Two pediatric cases demonstrating the range of severity in presentation--A case of vancomycin-induced drug hypersensitivity mimicking toxic shock syndrome and a milder case induced by minocycline.

Authors:  Amy E Vinson; Elizabeth M Dufort; Matthew D Willis; Craig P Eberson; Joseph I Harwell
Journal:  Pediatr Crit Care Med       Date:  2010-07       Impact factor: 3.624

Review 5.  The DRESS syndrome: a literature review.

Authors:  Patrice Cacoub; Philippe Musette; Vincent Descamps; Olivier Meyer; Chris Speirs; Laetitia Finzi; Jean Claude Roujeau
Journal:  Am J Med       Date:  2011-05-17       Impact factor: 4.965

Review 6.  Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses.

Authors:  Tetsuo Shiohara; Miyuki Inaoka; Yoko Kano
Journal:  Allergol Int       Date:  2006-03       Impact factor: 5.836

Review 7.  The immunological and clinical spectrum of delayed drug-induced exanthems.

Authors:  Marianne Lerch; Werner J Pichler
Journal:  Curr Opin Allergy Clin Immunol       Date:  2004-10

8.  Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome.

Authors:  M Tohyama; K Hashimoto; M Yasukawa; H Kimura; T Horikawa; K Nakajima; Y Urano; K Matsumoto; M Iijima; N H Shear
Journal:  Br J Dermatol       Date:  2007-09-13       Impact factor: 9.302

9.  A 6-month prospective survey of cutaneous drug reactions in a hospital setting.

Authors:  F Fiszenson-Albala; V Auzerie; E Mahe; R Farinotti; C Durand-Stocco; B Crickx; V Descamps
Journal:  Br J Dermatol       Date:  2003-11       Impact factor: 9.302

10.  Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6 reactivation and hypogammaglobulinemia.

Authors:  Yoko Kano; Miyuki Inaoka; Tetsuo Shiohara
Journal:  Arch Dermatol       Date:  2004-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.